DJIA 18,162.59 121.05 0.67%
NASDAQ 5,090.79 58.04 1.15%
S&P 500 2,120.68 16.48 0.78%
market minute promo

Biogen Idec (NASDAQ: BIIB)

401.10 8.22 (2.09%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $401.09 2.09%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $393.81
Previous Close $392.88
Daily Range $391.52 - $401.34
52-Week Range $290.85 - $480.18
Market Cap $94.4B
P/E Ratio 28.39
Dividend (Yield) $0.00 (0.0%)
Volume 630,175
Average Daily Volume 1,871,209
Current FY EPS $16.70




Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website:

News & Commentary Rss Feed

Pop! 3 To Buy If Biotech Stocks Burst

Biotech stocks are falling slightly from their lofty levels, and that may create some interesting opportunities to buy.

Amazon, Apple and Chipotle Too Pricey for Your Portfolio? There's an ETF for That

Healthcare Investment Opportunities for the Long Term

Three healthcare investment opportunities that could be profitable for decades to come.

Stock Market News for May 21, 2015 - Market News

Jim Cramer Answers Your Twitter Questions on Tesla, Jarden, Williams-Sonoma, Wayfair

3 Drugs Stocks Nudging The Industry Higher

5 NASDAQ Healthcare Stocks With The Highest EPS

Stocks End Narrowly Mixed as Oil Closes at May Low

Biosimilars Vs Generics: History Does Not Repeat, It Rhymes

3 Best Biotech Stocks to Add to Your Portfolio

See More BIIB News...

BIIB's Top Competitors

BIIB $401.10 (2.09%)
Current stock: BIIB
AMGN $159.85 (0.53%)
Current stock: AMGN
GILD $112.17 (2.19%)
Current stock: GILD
$0.00 (0.00%)
Current stock: